PPT-Transcarotid Artery Revascularization

versus Transfemoral Carotid Artery Stenting for Treatment of Carotid Artery Stenosis Patric Liang MD Marc L Schermerhorn MD Jens EldrupJorgensen MD Jack L Cronenwett MD Brian W Nolan MD Vikram S Kashyap MD . . c. oronary. . d. isease. . d. iagnosed. . at the . t. ime. . of . p. rimary. . PCI for STEMI: . c. omplete. . r. evascularization. . v. ersus. . c. onservative. . s. trategy. . . PRAGUE . Sergio . Leonardi. , L. Kristin Newby, E. Magnus . Ohman. , Paul W. Armstrong.. November 16. th. 2010. . Chicago, IL – AHA Scientific Sessions. Disclosures Information. None of the authors have relevant financial disclosures. bypass grafting in treatment of unprotected left . main stenosis. Nordic–Baltic–British . left main . revascularisation study . (NOBLE. ). A . prospective, randomised, open-label. , non-inferiority trial. –. DEFINE-FLAIR . Justin E Davies, MD, . PhD on behalf of the DEFINE-FLAIR investigators. Hammersmith Hospital, . Imperial College London. F. unctional . L. esion . A. ssessment of . I. ntermediate stenosis to guide . vs. FFR-guided . Coronary Intervention . –. . iFR. -SWEDEHEART. Matthias Götberg, . MD, . PhD. Department of Cardiology, Lund University. Skane. University Hospital. Lund, Sweden. Disclosures. Volcano/Philips: Unrestricted grant to fund . VIABILITY. CORONARY ARTERY DISEASE. ACUTE CORONARY SYNDROME. Undergo . revascularisation. procedures. . Improved survival. Increased number of patients with residual LV dysfunction undergoing progressive LV remodeling and congestive heart failure. Revascularization in Stable Ischemic Heart Disease. Bobby Mathew, MD. LSU Internal Medicine, HO-II. Definitions. Recommendations for revascularization in the setting of symptomatic, stable ischemic heart disease; does not include revascularization in the setting of acute MI. Michael . neilson. , MD. 1. Mahmoud malas, MD, MHS. 2. Grace wang, MD. 3. Vikram Kashyap, MD. 4. Raghu . motaganahalli. , MBBS. 4. Marc Schermerhorn, MD. 5. Jack . cronenwett. , MD. 6. Jens . Eldrup. DEPARTMENT OF VETERANS AFFAIRS Mortality and Revascularization Following Admission for AMI: Implications for Rural Veterans Thad E. Abrams, MD, MS, Mary Vaughn-Sarrazin, PhD, Pe Veterans Rural . 2021 ACC/AHA/SCAI Guideline of Coronary Artery Revascularization. Table 1. . Applying. . ACC/AHA Class of Recommendation and Level of Evidence to Clinical Strategies, Interventions, Treatments, or Diagnostic Testing in Patient Care . vs.. . c. oronary artery bypass for multi-vessel disease: a meta-analysis. . Nirav C Patel MD, Jonathan M Hemli MD, Karthik Seetharam MD, Annapoorna Uttara BS, Derek R Brinster MD,. . Luigi Pirelli MD, Chad . CLINICAL . 87 year old female presents with abdominal pain with food intake resulting in food aversion and failure to thrive. . Past medical history significant for 2 layers of stents in SMA artery, last being DES in 12/2020. Known occluded celiac artery. . iFR-Swedeheart. 5-year outcome. Matthias Götberg, MD, PhD. Skane. University Hospital, Lund University, Sweden. - on behalf of the . iFR-Swedeheart. investigators. Within the past 12 months, I or my spouse/partner have had a financial interest/arrangement or affiliation with the organization(s) listed below.. on behalf of the OPTIMUM Investigators. O. utcomes of . P. ercutaneous . Revasculariza. TI. on. for . M. anagement of . S. U. rgically. Ineligible Patients with . M. ultivessel or Left Main Coronary Artery Disease: Primary Results from the .